Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy

Clinical trial NCT07750678 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07750678
Sponsor: GenEditBio Limited
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Corneal Dystrophy Corneal Abnormality Corneal Dystrophies Corneal Dystrophies, Hereditary

Start date: 2026-08-01
Primary completion: 2027-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.